open access

Vol 77, No 6 (2009)
ORIGINAL PAPERS
Published online: 2009-11-30
Submitted: 2013-02-22
Get Citation

Leptin serum levels in cachectic and non-cachectic lung cancer patients

Bożena Weryńska, Monika Kosacka, Marcin Gołecki, Renata Jankowska
Pneumonol Alergol Pol 2009;77(6):500-506.

open access

Vol 77, No 6 (2009)
ORIGINAL PAPERS
Published online: 2009-11-30
Submitted: 2013-02-22

Abstract


Introduction: Leptin, protein taking part in body mass regulation, might play a role in cancer cachexia development. The aim of the study was to measure leptin serum levels in cachectic, non-cachectic lung cancer patients, healthy controls and to correlate leptin concentration with nutritional status markers.
Material and methods: 40 lung cancer patients were enrolled into the study: 20 with cachexia, 20 without cachexia, and 10 healthy controls. Leptin serum concentration, body mass, BMI, arm circumference and skin triceps fold thickness were measured in each subject.
Results: Serum leptin level in cachectic cancer patients was significantly lower than in non-cachectic and healthy controls. Leptin concentration correlated with body mass, arm circumference and skin triceps fold thickness.
Conclusions: Cachectic lung cancer patients have significantly lower serum leptin concentrations than non-cachectic patients and healthy controls which may suggest, that leptin does not play an important role in cancer cachexia development. Leptin levels positively correlate with good nutritional status markers. Non-cachectic lung cancer patients have similar leptin serum levels as healthy controls.

Abstract


Introduction: Leptin, protein taking part in body mass regulation, might play a role in cancer cachexia development. The aim of the study was to measure leptin serum levels in cachectic, non-cachectic lung cancer patients, healthy controls and to correlate leptin concentration with nutritional status markers.
Material and methods: 40 lung cancer patients were enrolled into the study: 20 with cachexia, 20 without cachexia, and 10 healthy controls. Leptin serum concentration, body mass, BMI, arm circumference and skin triceps fold thickness were measured in each subject.
Results: Serum leptin level in cachectic cancer patients was significantly lower than in non-cachectic and healthy controls. Leptin concentration correlated with body mass, arm circumference and skin triceps fold thickness.
Conclusions: Cachectic lung cancer patients have significantly lower serum leptin concentrations than non-cachectic patients and healthy controls which may suggest, that leptin does not play an important role in cancer cachexia development. Leptin levels positively correlate with good nutritional status markers. Non-cachectic lung cancer patients have similar leptin serum levels as healthy controls.
Get Citation

Keywords

lung cancer; cancer cachexia; leptin

About this article
Title

Leptin serum levels in cachectic and non-cachectic lung cancer patients

Journal

Advances in Respiratory Medicine

Issue

Vol 77, No 6 (2009)

Pages

500-506

Published online

2009-11-30

Bibliographic record

Pneumonol Alergol Pol 2009;77(6):500-506.

Keywords

lung cancer
cancer cachexia
leptin

Authors

Bożena Weryńska
Monika Kosacka
Marcin Gołecki
Renata Jankowska

References (17)
  1. Nelson KA. The cancer anorexia-cachexia syndrome. Semin Oncol. 2000; 27: 64–68.
  2. Kosacka M, Weryńska B, Gołecki M, et al. Występowanie oraz patogeneza zespołu jadłowstrętu i wyniszczenia nowotworowego w raku płuca. Pneumonol Alergol Pol. 2008; 76: 360–365.
  3. Hang Y, Proenca R, Maffei M, et al. Positional cloning of the obese gene and its human homologue. Nature. 1994; 372: 425–432.
  4. Meyers J, McTiernan A, Ulrich C. Leptin and immune function: integrating the evidence. Nutrition Research. 2005; 25(9): 791–803.
  5. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996; 334(5): 292–295.
  6. Caro JF, Kolaczynski JW, Nyce MR, et al. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet. 1996; 348(9021): 159–161.
  7. Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol. 1998; 30(12): 1285–1290.
  8. Sato T, Meguid MM, Miyata Go, et al. Does leptin really influence cancer anorexia? Nutrition. 2002; 18(1): 82–83.
  9. Krzakowski M. Onkologia kliniczna. Borgis Wydawnictwo Medyczne, Warszawa 2006.
  10. Kosacka M, Jankowska R. Epidemiologia raka płuca. Pneumonol Alergol Pol. 2007; 75: 76–80.
  11. Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr. 2001; 74(3): 295–301.
  12. Simons JP, Schols AM, Campfield LA, et al. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond). 1997; 93(3): 273–277.
  13. Alemán MR, Santolaria F, Batista N, et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine. 2002; 19(1): 21–26.
  14. Tas F, Duranyildiz D, Argon A, et al. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med Oncol. 2005; 22(4): 353–358.
  15. Jamieson NB, Brown DJF, Michael Wallace A, et al. Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer. Cytokine. 2004; 27(2-3): 90–92.
  16. Bączyk M, Gorzelińska L, Łuczak J, et al. Zespół wyniszczenia nowotworowego. Wpływ leczenia na wybrane parametry kliniczne i biochemiczne. Doniesienie wstępne Pol Med Paliat. 2005; 4: 11–16.
  17. Elinav E, Niv-Spector L, Katz M, et al. Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology. 2009; 150(7): 3083–3091.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl